Partnership : Academics = 
, Industrials = 
, Financial investitors = 
-
- CANADA
- Colombie-Britannique
- VANCOUVER
- FORGE - Finding of Rare Disease Genes in Canada
- University of British Columbia
- Faculty of Medicine
- More details
-
- CANADA
- Ontario
- OTTAWA, ONTARIO
- FORGE - Finding of Rare Disease Genes in Canada
- University of Ottawa
- Faculty of Medicine -
- More details
-
- FORGE - Finding of Rare Disease Genes in Canada
- Centre hospitalier universitaire Sainte-Justine
- Pédiatrie
- More details
-
- Physiopathological mechanisms of polyglutamine expansion diseases
- Institut de génétique et de biologie moléculaire et cellulaire - IGBMC
- Département Neurobiologie et Génétique
- More details
-
- FRANCE
- AQUITAINE
- BORDEAUX
- Histo-pathologic study of prion diseases
- CHU de Bordeaux-GH Pellegrin
- Laboratoire d'anatomie pathologique
- More details
-
- FRANCE
- AQUITAINE
- BORDEAUX
- AMYLOI: use of yeasts to search molecular basis of toxicity of type ''prions'' infectious amyloids
- Université Bordeaux 2 - Victor Ségalen
- Hérédité structurale et prion
- More details
-
- FRANCE
- ILE-DE-FRANCE
- FONTENAY-AUX-ROSES
- NEUROPRION: European network dedicated to research on prion diseases (coordination)
- CEA - Commissariat à l'Energie Atomique
- Service d'étude des prions et des infections atypiques
- More details
-
- FRANCE
- ILE-DE-FRANCE
- PARIS
- BIOSCA:Biomarkers in Autosomal Dominant Cerebellar Ataxia
- CHU Paris-GH La Pitié Salpêtrière-Charles Foix - Hôpital Pitié-Salpêtrière
- UF de Neurogénétique moléculaire et cellulaire
- More details
-
- FRANCE
- ILE-DE-FRANCE
- PARIS
- RISCA: étude prospective des individus à risque for l'ataxie spinocérébelleuse de type 1, 2, 3 et 6 (SCA1, SCA2, SCA3, SCA6) (partenaire No. 3)
- CHU Paris-GH La Pitié Salpêtrière-Charles Foix - Hôpital Pitié-Salpêtrière
- Institut du Cerveau et de la Moëlle épinière
- More details
-
- FRANCE
- ILE-DE-FRANCE
- PARIS
- Transmission and pathogenesis of prion diseases
- CHU Paris-GH St Louis Lariboisière F.Widal - Hôpital Lariboisière
- Service de biochimie et biologie moléculaire
- More details
-
- FRANCE
- ILE-DE-FRANCE
- PARIS
- Physiopathology of central nervous system diseases by polyglutamine expansion
- Centre Universitaire des Saints-Pères
- Régulation de la transcription et maladies génétiques
- More details
-
- FRANCE
- LANGUEDOC-ROUSSILLON
- MONTPELLIER
- Normal and pathological function of the prion protein
- Institut de Recherches en Biothérapie (IRB)
- INSERM U1040
- More details
-
- FRANCE
- NORD-PAS-DE-CALAIS
- LILLE
- European information project on rare forms of dementia
- Centre de Recherches Jean-Pierre Aubert (CRJPA)
- Maladies neurodégénératives et mort neuronale
- More details
-
- FRANCE
- PROVENCE-ALPES-COTE D'AZUR
- MARSEILLE
- Caring and treatment of progressive myoclonic epilepsies
- Hôpital Henri Gastaut
- Centre Saint Paul
- More details
-
- GERMANY
- Baden-Württemberg
- TÜBINGEN
- RISCA: Prospective study of individuals at risk for spinocerebellar ataxia type 1, type 2, type 3 and type 6 (SCA1, SCA2, SCA3, SCA6) (partner No. 5)
- Hertie-Institut für klinische Hirnforschung
- Sektion klinische Neurogenetik
- More details
-
- GERMANY
- Baden-Württemberg
- TÜBINGEN
- RISCA: Prospective study of individuals at risk for spinocerebellar ataxia type 1, type 2, type 3 and type 6 (SCA1, SCA2, SCA3, SCA6) (partner No. 6)
- Universitätsklinikum Tübingen
- Medizinische Genetik Tübingen
- More details
-
- GERMANY
- Baden-Württemberg
- TÜBINGEN
- Study of the pathophysiological function of ataxin-3 and of factors influencing the age-onset of spinocerebellar ataxia type 3 (SCA3) in a mouse model.
- Universitätsklinikum Tübingen
- Medizinische Genetik Tübingen
- More details
-
- GERMANY
- Baden-Württemberg
- TÜBINGEN
- TreatPolyQ: factors that control the intracellular localization of ataxin-3
- Universitätsklinikum Tübingen
- Medizinische Genetik Tübingen
- More details
-
- GERMANY
- Baden-Württemberg
- TÜBINGEN
- TreatPolyQ: Industrial Academic Initial Training Network (Itn) Towards Treatment Of Polyglutamine Diseases (coordination)
- Universitätsklinikum Tübingen
- Medizinische Genetik Tübingen
- More details
-
- GERMANY
- Bayern
- MARTINSRIED
- Cellular Toxicity of Polyglutamine Proteins in Neurodegenerative Disease
- Max-Planck-Institut für Biochemie
- Abteilung zelluläre Biochemie
- More details
-
- Biochemical and pathophysiological properties of mutant prion proteins (SFB 596)
- Ludwig-Maximilians-Universität München
- Neurobiochemie
- More details
-
- BNE: BrainNet Europe II: European brain tissue bank - Network for clinical neuroscience and basic research (coordination)
- Ludwig-Maximilians-Universität München
- Zentrum für Neuropathologie und Prionforschung
- More details
-
- EMINA: European multidisciplinary initiative on neuroacanthocytosis (coordination)
- Ludwig-Maximilians-Universität München
- Zentrum für Neuropathologie und Prionforschung
- More details
-
- Molecular and cellular biology and pathology of prion diseases
- Technische-Universität München
- Fachgebiet Klinische Virologie
- More details
-
- Analysis of prion protein genes in the context of the species barrier
- Technische-Universität München
- Fachgebiet Klinische Virologie
- More details
-
- Analysis of prion strain dissemination and the role of glycosaminoglycans in prion cell culture models (SFB 596)
- Technische-Universität München
- Fachgebiet Klinische Virologie
- More details
-
- GERMANY
- Hessen
- FRANKFURT AM MAIN
- CAG102-knock-in model for spinocerebellar ataxia type 2
- Klinikum der Johann Wolfgang Goethe-Universität Frankfurt
- Klinik für Neurologie
- More details
-
- GERMANY
- Hessen
- FRANKFURT AM MAIN
- The effect of normal and pathological ataxin-2 on regulation of protein synthesis in neurons
- Klinikum der Johann Wolfgang Goethe-Universität Frankfurt
- Klinik für Neurologie
- More details
-
- GERMANY
- Niedersachsen
- GÖTTINGEN
- EUROSPIN: European consortium on synaptic protein networks in Neurological and Psychiatric diseases (coordination)
- Max-Planck-Institut für experimentelle Medizin
- Abteilung Molekulare Neurobiologie
- More details
-
- GERMANY
- Nordrhein-Westfalen
- AACHEN
- RISCA: Prospective study of individuals at risk for spinocerebellar ataxia type 1, type 2, type 3 and type 6 (SCA1, SCA2, SCA3, SCA6) (partner No. 7)
- Universitätsklinikum Aachen
- Neurologische Klinik
- More details
-
- GERMANY
- Nordrhein-Westfalen
- BONN
- PPPT-MJD - towards the understanding of pathological protein processing and toxicity in Machado-Joseph Disease (coordination)
- Universitätsklinikum Bonn
- Institut für Rekonstruktive Neurobiologie
- More details
-
- GERMANY
- Nordrhein-Westfalen
- BONN
- Development of a strategy for somatic genetherapy in neurodegenerative diseases on basis of RNA interference using transgenic mouse models of prion diseases
- Universitätsklinikum Bonn
- Institut für Pharmakologie und Toxikologie
- More details
-
- GERMANY
- Nordrhein-Westfalen
- BONN
- GeNeMove: Natural history of spinocerebellar Ataxia type 3 (SCA3)
- Universitätsklinikum Bonn
- Klinik und Poliklinik für Neurologie
- More details
-
- GERMANY
- Nordrhein-Westfalen
- BONN
- SCA3 knock-out mouse
- Universitätsklinikum Bonn
- Klinik und Poliklinik für Neurologie
- More details
-
- GERMANY
- Nordrhein-Westfalen
- BONN
- RISCA: Prospective study of individuals at risk for spinocerebellar ataxia type 1, type 2, type 3 and type 6 (SCA1, SCA2, SCA3, SCA6) (coordination)
- Universitätsklinikum Bonn
- Klinik und Poliklinik für Neurologie
- More details
-
- GERMANY
- Nordrhein-Westfalen
- DÜSSELDORF
- ANTEPRION: PrPsc binding molecules and particulates
- Heinrich-Heine Universität Düsseldorf
- Institut für Neuropathologie - AG Korth
- More details
-
- Role of intracellular trafficking in the pathogenesis of inherited prion diseases
- Azienda Ospedaliera Universitaria "Federico II"
- Dipartimento di Biologia e Patologia cellulare
- More details
-
- The role of iron and mitochondria in the pathogenesis of Pantothenate Kinase Associated Neurodegeneration (PKAN): development of new neuronal cellular systems and analysis of a mouse model
- Università degli Studi di Brescia
- Dipartimento di Scienze Biomediche e Biotecnologie
- More details
-
- RISCA: studio prospettico per l'individuazione del rischio per l'atassia spinocerebellare tipo1, tipo2, tipo3 e tipo 6 (SCA1, SCA2, SCA3, SCA6) (partner No. 4)
- Fondazione IRCCS Istituto Neurologico "Carlo Besta"
- U.O. Biochimica e Genetica
- More details
-
- A drosophila model to study the neurodegenerative disease Dentatorubral-pallidoluysian atrophy
- IRCCS Ospedale San Raffaele - DIBIT
- Dipartimento di Genomica Funzionale
- More details
-
- Neurodegeneration in Polyglutamine tract expansion related diseases
- Università degli Studi di Milano
- Dipartimento di Scienze Farmacologiche e Biomolecolari
- More details
-
- Analysis of functional and post-traslational modifications in abnormal red cells from neuroacanthocytosis
- Azienda Ospedaliera Universitaria Integrata di Verona - Ospedale Borgo Roma
- Dipartimento di Medicina Clinica e Sperimentale
- More details
-
- NETHERLANDS
- Noord-Holland
- AMSTERDAM
- ANTEPRION: Identification of WBC populations and sub-fractions enriched for PrPsc
- Het Nederlands Kanker Instituut - Antoni van Leeuwenhoek Ziekenhuis
- Groep Tumorbiologie
- More details
-
- NETHERLANDS
- Noord-Holland
- AMSTERDAM
- ANTEPRION: development of a pre-clinical blood test for prion diseases (coordination)
- Het Nederlands Kanker Instituut - Antoni van Leeuwenhoek Ziekenhuis
- Groep Tumorbiologie
- More details
-
- The role of calpain-mediated proteolysis of ataxin-3 in Machado-Joseph disease: a molecular therapy approach with viral vectors.
- Centro de Neurociências da Universidade de Coimbra
- Departmento de vectores e terapia génica
- More details
-
- Regulation by phosphorylation of ataxin-3, the mutated protein in Machado Joseph Disease
- Centro de Neurociências da Universidade de Coimbra
- Glutamatergic Synapses: Formation and regulation of synapses
- More details
-
- Screening of therapeutic compounds in a C. elegans model of Machado-Joseph disease
- Instituto de Ciências da Vida e da Saúde - Universidade do Minho
- Grupo de Neurociências
- More details
-
- A peptide aptamer-based approach to neurodegenerative disorders.
- Instituto de Biologia Molecular e Celular
- Protein Crystallography Group
- More details
-
- Search for disease modifiers in spinocerebellar ataxias: human and animal-based approaches.
- Instituto de Biologia Molecular e Celular
- Unidade de Investigação Genética e Epidemiológica em Doenças Neurológicas
- More details
-
- Single-Molecule Detection of the Prion Protein: Characterization of Conformational Change Involved on Prion Diseases.
- Universidade do Algarve
- Centro de Biomedicina Molecular e Estrutural
- More details
-
- The role of calpain-mediated proteolysis of ataxin-3 in Machado-Joseph disease: a molecular therapy approach with viral vectors.
- Fundação para Ciência e a Tecnologia
- More details
-
- SPAIN
- Cantabria
- SANTANDER
- RISCA: prospective study of individuals at risk for spinocerebellar ataxia type 1, type 2, type 3 and type 6 (SCA1, SCA2, SCA3, SCA6) (partner No. 2)
- HUMV - Hospital Universitario Marqués de Valdecilla
- Servicio de Neurología (HUMV)
- More details
-
- Molecular pathogenesis of Spinocerebellar Ataxia type 1 (SCA1)
- Fundació Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol
- Departamento de Neurociencias y Servicio de Neurología
- More details
-
- Functional studies with Ataxin 1
- Fundació Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol
- Departamento de Neurociencias y Servicio de Neurología
- More details
-
- Investigation of the molecular basis underlying pathogenesis in spinocerebellar ataxia type 1 (SCA1): towards the development of effective therapeutic strategies
- Fundació Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol
- Departamento de Neurociencias y Servicio de Neurología
- More details
-
- Potential of cannabinoids as neuroprotective agents in neurodegenerative disorders: Huntington disease, amyotrophic lateral sclerosis and spinocerebellar ataxia, types 2 and 3
- Universidad Complutense de Madrid. Facultad de Medicina
- Grupo de Neuroquímica de los Cannabinoides
- More details
-
- SWEDEN
- Stockholms läns landsting
- STOCKHOLM
- The role of an atrophin-brakeless protein complex in gene regulation and neurodegeneration in particularly
- Stockholm University
- Developmental Biology
- More details
-
- UNITED KINGDOM
- Greater London
- LONDON
- Evaluation of RNA trans-splicing therapy for Spinocerebellar Ataxia type 1: A pilot study
- Institute of Psychiatry - King's College London
- MRC Centre for Neurodegeneration Research
- More details
-
- UNITED KINGDOM
- Greater London
- LONDON
- Disruption of balance in spinocerebellar ataxia: Developing targeted therapies
- National Hospital for Neurology and Neurosurgery
- Sobell Department of Motor Neuroscience and Movement Disorders
- More details
-
- UNITED KINGDOM
- Greater London
- LONDON
- Disruption of balance in spinocerebellar ataxia: Developing targeted therapies
- National Hospital for Neurology and Neurosurgery
- Department of Molecular Neuroscience
- More details
-
- UNITED KINGDOM
- Greater London
- LONDON
- Structural studies of polyglutamine expansion disease proteins
- School of Biomedical sciences - King's College London
- Randall Division of Cell and Molecular Biophysics
- More details
-
- UNITED KINGDOM
- Oxfordshire
- OXFORD
- Development of new tools for the analysis of chorein and other vps13 proteins
- The Wellcome Trust Centre for Human Genetics
- Neurodevelopmental and Neurological Disorders Group
- More details
